Donald Emlay Net Worth

The estimated Net Worth of Don Emlay is at least $52.7 Tisíc dollars as of 10 September 2015. Mr. Emlay owns over 10,000 units of Arcadia Biosciences Inc stock worth over $52,675 and over the last 9 years he sold RKDA stock worth over $0. In addition, he makes $0 as Vice President - Regulatory Affairs and Compliance at Arcadia Biosciences Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Emlay RKDA stock SEC Form 4 insiders trading

Donald has made over 2 trades of the Arcadia Biosciences Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 10,000 units of RKDA stock worth $4,400 on 10 September 2015.

The largest trade he's ever made was exercising 10,000 units of Arcadia Biosciences Inc stock on 10 September 2015 worth over $4,400. On average, Donald trades about 10,000 units every 0 days since 2015. As of 10 September 2015 he still owns at least 18,418 units of Arcadia Biosciences Inc stock.

You can see the complete history of Mr. Emlay stock trades at the bottom of the page.

Donald Emlay biography

Don Emlay is Vice President - Regulatory Affairs and Compliance at Arcadia Biosciences, Inc. since June 2004. Mr. Emlay has nearly 40 years of regulatory experience with consumer, industrial, and transgenic plant products. Prior to joining our company, Mr. Emlay was an independent consultant and provided counsel in the areas of research, product development, production, and regulatory procedures. Before his work as a consultant, Mr. Emlay served as Vice President of Regulatory Affairs with Calgene Inc. for 13 years, including three years with Monsanto Company following its acquisition of Calgene. Prior to Calgene and Monsanto, Mr. Emlay worked with Zoecon where he worked exclusively with the EPA in obtaining approvals for the first insect growth regulators to be registered for homeowner and pest control applications. Mr. Emlay holds a B.S. in Entomology from San Jose State University.

How old is Donald Emlay?

Donald Emlay is 73, he's been the Vice President - Regulatory Affairs and Compliance of Arcadia Biosciences Inc since 2004. There are no older and 11 younger executives at Arcadia Biosciences Inc.

What's Donald Emlay's mailing address?

Don's mailing address filed with the SEC is C/O ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105, DAVIS, CA, 95618.

Insiders trading at Arcadia Biosciences Inc

Over the last 10 years, insiders at Arcadia Biosciences Inc have traded over $35,492 worth of Arcadia Biosciences Inc stock and bought 2,813,834 units worth $22,335,794 . The most active insiders traders include Terri Csperling Peter V Mor..., Darby E Shupp a Albert D. Bolles. On average, Arcadia Biosciences Inc executives and independent directors trade stock every 49 days with the average trade being worth of $147,899. The most recent stock trade was executed by Mark Kawakami on 1 August 2024, trading 700 units of RKDA stock currently worth $1,442.

What does Arcadia Biosciences Inc do?

arcadia biosciences (nasdaq: rkda) develops and markets high-value food ingredients and nutritional oils that help meet consumer demand for a healthier diet. arcadia’s goodwheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. the company’s portfolio of agricultural traits are being developed to enable farmers around the world to be more productive and minimize the impact of agriculture on the environment. for more information visit www.arcadiabio.com.

Complete history of Mr. Emlay stock trades at Arcadia Biosciences Inc

Arcadia Biosciences Inc executives and stock owners

Arcadia Biosciences Inc executives and other stock owners filed with the SEC include:

• Pamela Haley,
  CFO & Corp. Sec.
• Laura Pitlik,
  Chief Marketing Officer
• Kevin J. Comcowich,
  Chairman & Interim CEO
• Amy Yoder,
  Director
• Gregory Waller,
  Director
• Lilian Shackleford Murray,
  Director
• Peter Gajdos,
  Director
• Albert Bolles,
  Director
• Jamie Bechtel,
  Director
• Sarah Reiter,
  Chief Commercial Officer
• Zhongjin Lu,
  Director - Product Development
• Kevin Hodges,
  Vice President - Commercial Operations
• Donald Emlay,
  Vice President - Regulatory Affairs and Compliance
• Tracy Baker,
  Vice President - Product Innovation
• Pamela Haley,
  Chief Financial Officer
• Matthew Plavan,
  Chief Executive Officer, Director
• Kevin Comcowich,
  Chairman of the Board
• Stanley E. Jacot Jr.,
  Pres, CEO & Director
• Stan Jacot,
  Pres & CEO
• Dr. Zhongjin Lu Ph.D.,
  Director of Product Devel.
• Brian Schaffer,
  Sr. VP of Sales
• Belinda Yao,
  VP of Operations
• George Frederick John Gosbee,
  Director
• Darby E Shupp,
  Director
• Rajiv Shah,
  Director
• Wendy S. Neal,
  VP, Chief Legal Officer
• James Richard Reis,
  Director
• Uday Garg,
  Director
• Matthew A. Ankrum,
  Director
• Steven F. Brandwein,
  VP Finance and Administration
• Roger Salameh,
  VP Business Development
• Mark Wong,
  Director
• Vic C. Knauf,
  Chief Scientific Officer
• Eric J. Rey,
  President and CEO
• Don Emlay,
  VP Regulatory and Compliance
• Agribusiness Co Investments...,
  
• Terri Csperling Peter V Mor...,
  
• Randall Shultz,
  Chief Technology Officer
• Chris Cuvelier,
  Chief Growth Officer
• Laura Pitlik,
  Chief Marketing Officer
• Stanley Jr Jacot,
  Chief Executive Officer
• Deborah D Carosella,
  
• Thomas J. Schaefer,
  Chief Executive Officer
• Mark Kawakami,
  Chief Financial Officer